Skip to content

US · CGC · DRUG MANUFACTURERS - SPECIALTY & GENERIC

Canopy Growth Corporation (CGC) intrinsic value and stock valuation

$0.43as of 2026-11-21 · Mkt cap 393.32M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Canopy Growth Corporation DCF and intrinsic value

InvestorsCraft values CGC with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from CGC’s statements →

Canopy Growth Corporation Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Drug Manufacturers - Specialty & Generic Smiths Falls, ON K7A 0A8 canopygrowth.com

How the business is doing

Fiscal 2011–2026, USD

Revenue
$284.6M-12.2% 5y CAGRd
20112026
Net income
-$-262.91M
20112026
Free cash flow
-$-69.76M
20112026
Total equity
$697.6M-28.1% 5y CAGRd
20112026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2026, USD
20262025202420232022
Revenue$284.6M$269M$297.2M$333.3M$475.7M
Operating income-$-73.11M-$-117.14M-$-228.71M-$-2.63B-$-1.02B
Net income-$-262.91M-$-598.12M-$-657.27M-$-3.28B-$-310.04M
EPSd-$-88.21K-$-5.56M-$-8.79M-$-70.7M-$-7.92M
Operating cash flow-$-63.81M-$-165.75M-$-281.95M-$-557.55M-$-545.81M
Capital expenditure-$-5.95M-$-11.28M-$-4M-$-10.45M-$-48.11M
Free cash flow-$-69.76M-$-177.03M-$-285.95M-$-568M-$-593.92M
Total assets$1.12B$917.7M$1.3B$2.44B$5.61B
Total debt$278.7M$348.4M$668M$1.41B$1.64B
Net debt-$-85.97M$234.6M$497.7M$746M$864.2M
Total equity$697.6M$487.2M$500.5M$760M$3.62B
Cash and short-term investments$370.7M$131.5M$203.5M$773.2M$1.37B
Income statement
20262025202420232022
Revenue$284.6M$269M$297.2M$333.3M$475.7M
Cost of revenue$214.9M$189.5M$216.3M$396.8M$663.1M
Gross profit$69.7M$79.5M$80.9M-$-63.53M-$-187.41M
Research and development expenses$0.00$1.91M$4.61M$21.7M$32.3M
Selling, general and administrative expenses$122.9M$121.7M$180.6M$298M$361.1M
Other expenses$19.9M$75M$124.4M$2.25B$438M
Operating expenses$142.8M$196.7M$309.6M$2.57B$831.4M
Cost and expenses$357.7M$386.1M$525.9M$2.96B$1.49B
Interest income$10M$8.81M$16.2M$24.3M$6.6M
Interest expense$38.2M$74.6M$105.4M$126.2M$103.9M
Depreciation and amortization$36.5M$43.1M$53.2M$80M$110.9M
Ebitda-$-188.22M-$-479.31M-$-312.83M-$-2.88B-$-52.98M
Operating income-$-73.11M-$-117.14M-$-228.71M-$-2.63B-$-1.02B
Total other income/expenses, net-$-189.78M-$-479.85M-$-242.64M-$-455.64M$750.9M
Income before tax-$-262.88M-$-597M-$-471.36M-$-3.09B-$-267.86M
Income tax expense$20K$7.14M$12.3M-$-5.73M-$-8.95M
Net income-$-262.91M-$-598.12M-$-657.27M-$-3.28B-$-310.04M
Weighted average shares outstanding$2.98B$107.6M$101.6M$46.4M$39.1M
Weighted average diluted shares outstanding$2.98B$107.6M$74.8M$46.4M$39.1M
Balance sheet
20262025202420232022
Cash and short-term investments$370.7M$131.5M$203.5M$773.2M$1.37B
Net receivables$36.3M$52.8M$51.9M$68.5M$86.6M
Inventory$154.1M$96.4M$77.3M$83.2M$204.5M
Total current assets$529.5M$294.6M$371.2M$1.08B$1.73B
Property, plant and equipment, net$441.4M$293.5M$320.1M$471.3M$942.8M
Goodwill and intangible assets$206.5M$133.2M$147.3M$246.3M$2.12B
Long-term investments$108.3M$35.3M$136.2M$568.3M$341.7M
Total non-current assets$589.3M$623.1M$929.2M$1.36B$3.88B
Total assets$1.12B$917.7M$1.3B$2.44B$5.61B
Accounts payable$34.8M$26.1M$28.7M$31.8M$64.3M
Short-term debt$30.6M$20.8M$119.1M$585.3M$47.3M
Deferred revenue$0.00$0.00$5.85M$0.00$0.00
Total current liabilities$158.4M$94.4M$234.7M$803.8M$213.2M
Long-term debt$248.2M$327.6M$548.9M$828.4M$1.59B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$262.7M$336.1M$565.1M$875.8M$1.77B
Capital lease obligations$45.4M$44.3M$70.8M$106.8M$139.2M
Total liabilities$421.1M$430.5M$799.8M$1.68B$1.98B
Common stock$9.23B$8.8B$8.24B$7.94B$7.48B
Retained earnings-$-11.14B-$-10.93B-$-10.33B-$-9.67B-$-6.38B
Accumulated other comprehensive income (loss)$10.5M$540K-$-16.05M-$-13.86M-$-42.28M
Total equity$697.6M$487.2M$500.5M$760M$3.62B
Total investments$113.4M$53M$169.4M$673.8M$937.4M
Total debt$278.7M$348.4M$668M$1.41B$1.64B
Net debt-$-85.97M$234.6M$497.7M$746M$864.2M
Cash flow statement
20262025202420232022
Net income-$-262.91M-$-604.14M-$-483.68M-$-3.08B-$-258.91M
Depreciation and amortization$36.5M$43.1M$53.2M$80M$110.9M
Stock-based compensation$4.27M-$-4.21M$14.2M$25.3M$46.7M
Change in working capital$20.7M-$-31.96M$3.97M$59M$205M
Accounts receivable$25.7M-$-4.49M-$-3.75M$6.24M$16.2M
Inventory$3.71M-$-17.71M$1.03M$68.4M$204.2M
Accounts payable$0.00$0.00$0.00$0.00$0.00
Net cash provided by operating activities-$-63.81M-$-165.75M-$-281.95M-$-557.55M-$-545.81M
Investments in property, plant and equipment-$-5.33M-$-10.81M-$-3.45M-$-9.11M-$-36.68M
Acquisitions, net-$-41.54M-$-6.97M-$-950K$14.9M$103.2M
Net cash used for investing activities-$-21.35M-$-47.79M$241.6M$433.4M$230.8M
Common stock issued$374.2M$385.4M$81.1M$1.05M$2.7M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$332.4M$148.7M-$-465.06M-$-19.69M-$-45.53M
Net change in cash$250.9M-$-56.49M-$-506.71M-$-99M-$-378.65M
Cash at end of period$364.7M$113.8M$170.3M$677M$776M
Operating cash flow-$-63.81M-$-165.75M-$-281.95M-$-557.55M-$-545.81M
Capital expenditure-$-5.95M-$-11.28M-$-4M-$-10.45M-$-48.11M
Free cash flow-$-69.76M-$-177.03M-$-285.95M-$-568M-$-593.92M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Canopy Growth Corporation

        Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.

        CEO
        Luc Mongeau
        Employees
        1.13K
        Beta
        2.41

        Explore

        Frequently asked questions

        What is the intrinsic value of Canopy Growth Corporation (CGC)?

        InvestorsCraft does not currently publish an intrinsic value for CGC. How the IC value is calculated.

        Is CGC undervalued?

        InvestorsCraft does not publish an undervaluation signal for CGC at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.